Allelic Loss on Chromosome 5q34 is Associated with Poor Prognosis in Hepatocellular Carcinoma

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 2008 Apr 4

PMID 18386060

Citations 8

Authors

P Saelee

S Wongkham

V Bhudhisawasdi

B Sripa

S Chariyalertsak

S Petmitr

Affiliations

Soon will be listed here.

Abstract

Purpose: To identify and characterize novel genetic alterations in hepatocellular carcinoma (HCC).

Methods: DNA was extracted from 29 HCC and corresponding normal tissues and amplified with 59 different 10-base arbitrary primers. A 550 bp DNA fragment amplified using primer Q-9 and which was present in 19 of 29 cases (66%) was cloned, sequenced, and compared with known nucleotide sequences deposited in Genome database, and quantified by real-time PCR.

Results: DNA alterations were found on chromosomes 5q34, 6p25.2 and 8q12.1 in 11 of 29 cases (38%), 7 of 29 cases (24%), and 12 of 29 cases (41%), respectively. Multivariate analysis showed that the allelic loss on chromosome 5q34 was an independent prognostic factor for poor survival of HCC patients, with the median survival time of 19 weeks for allelic loss versus 109 weeks for no allelic loss (P = 0.001).

Conclusions: This study indicates that allelic loss on chromosome 5q34 may be involved in the development of HCC and could be used as a prognostic indicator in HCC patients.

Citing Articles

Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment.

Sogbe M, Bilbao I, Marchese F, Zazpe J, De Vito A, Pozuelo M Clin Mol Hepatol. 2024; 30(2):177-190.

PMID: 38163441 PMC: 11016491. DOI: 10.3350/cmh.2023.0426.

Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review.

Norton P, Mehta A World J Gastroenterol. 2019; 25(23):2947-2960.

PMID: 31249452 PMC: 6589740. DOI: 10.3748/wjg.v25.i23.2947.

microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.

Zhang Z, Zhang Y, Sun X, Ma X, Chen Z Mol Cancer. 2015; 14:5.

PMID: 25608619 PMC: 4326400. DOI: 10.1186/1476-4598-14-5.

An Overview of Biomarkers and Molecular Signatures in HCC.

Yim S, Chung Y Cancers (Basel). 2013; 2(2):809-23.

PMID: 24281095 PMC: 3835106. DOI: 10.3390/cancers2020809.

Decreased expression and prognostic role of mitogen-activated protein kinase phosphatase 4 in hepatocellular carcinoma.

Liu J, Ni W, Xiao M, Jiang F, Ni R J Gastrointest Surg. 2013; 17(4):756-65.

PMID: 23325341 DOI: 10.1007/s11605-013-2138-0.

References

Zhu G, Zuo L, Zhou Q, Zhang S, Zhu H, Gui S . Loss of heterozygosity on chromosome 10q22-10q23 and 22q11.2-22q12.1 and p53 gene in primary hepatocellular carcinoma. World J Gastroenterol. 2004; 10(13):1975-8. PMC: 4572244. DOI: 10.3748/wjg.v10.i13.1975. View

Faulkner S, Leigh D, Oosterhuis J, Roelofs H, Looijenga L, Friedlander M . Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model. Br J Cancer. 2000; 83(6):729-36. PMC: 2363524. DOI: 10.1054/bjoc.2000.1334. View

Shin J, Kang S, Kim Y, Shin D, Chang J, Kim S . Identification of tumor suppressor loci on the long arm of chromosome 5 in pulmonary large cell neuroendocrine carcinoma. Chest. 2005; 128(4):2999-3003. DOI: 10.1378/chest.128.4.2999. View

Miller S, Dykes D, Polesky H . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3):1215. PMC: 334765. DOI: 10.1093/nar/16.3.1215. View

EDMONDSON H, STEINER P . Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954; 7(3):462-503. DOI: 10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e. View

Kawakami K, Yasuda J, Shiraishi M, Kayama T, Doi K, Perucho M . Detection of DNA abnormalities by arbitrarily primed PCR fingerprinting: allelic losses in chromosome 10q in lung cancers. Biochem Biophys Res Commun. 1998; 251(1):153-7. DOI: 10.1006/bbrc.1998.9418. View

G Williams J, Kubelik A, Livak K, Rafalski J, Tingey S . DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res. 1990; 18(22):6531-5. PMC: 332606. DOI: 10.1093/nar/18.22.6531. View

Pakeetoot T, Punyarit P, Petmitr S . Novel DNA amplification on chromosomes 6q23-24 and 4p15.2 in breast cancer identified by arbitrarily primed polymerase chain reaction. J Exp Clin Cancer Res. 2007; 26(2):253-9. View

Hsu L, Lee H, Chau G, Yin P, Chi C, Lui W . Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Oncol Rep. 2006; 15(2):507-11. View

10.

Elmileik H, Paterson A, Kew M . Beta-catenin mutations and expression, 249serine p53 tumor suppressor gene mutation, and hepatitis B virus infection in southern African Blacks with hepatocellular carcinoma. J Surg Oncol. 2005; 91(4):258-63. DOI: 10.1002/jso.20304. View

11.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

12.

Navarro J, Jorcano J . The use of arbitrarily primed polymerase chain reaction in cancer research. Electrophoresis. 1999; 20(2):283-90. DOI: 10.1002/(SICI)1522-2683(19990201)20:2<283::AID-ELPS283>3.0.CO;2-N. View

13.

Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M . Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res. 1994; 54(12):3107-10. View

14.

Fukai K, Yokosuka O, Imazeki F, Tada M, Mikata R, Miyazaki M . Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma. Liver Int. 2005; 25(6):1209-16. DOI: 10.1111/j.1478-3231.2005.01162.x. View

15.

Chuensumran U, Wongkham S, Pairojkul C, Chauin S, Petmitr S . Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma. World J Gastroenterol. 2007; 13(21):2986-91. PMC: 4171154. DOI: 10.3748/wjg.v13.i21.2986. View

16.

Badvie S . Hepatocellular carcinoma. Postgrad Med J. 2000; 76(891):4-11. PMC: 1741466. DOI: 10.1136/pmj.76.891.4. View

17.

Xian Z, Cong W, Zhang S, Wu M . Genetic alterations of hepatocellular carcinoma by random amplified polymorphic DNA analysis and cloning sequencing of tumor differential DNA fragment. World J Gastroenterol. 2005; 11(26):4102-7. PMC: 4502110. DOI: 10.3748/wjg.v11.i26.4102. View

18.

Welsh J, McClelland M . Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res. 1990; 18(24):7213-8. PMC: 332855. DOI: 10.1093/nar/18.24.7213. View

19.

Parkin D, Pisani P, Ferlay J . Global cancer statistics. CA Cancer J Clin. 1999; 49(1):33-64, 1. DOI: 10.3322/canjclin.49.1.33. View

20.

Kohno T, Morishita K, Takano H, Shapiro D, Yokota J . Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting. Oncogene. 1994; 9(1):103-8. View